From a Pro Football Hall of Famer announcing his diagnosis to an R&B star’s latest update, here’s what’s happening in the ...

Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

A combination of presurgical Zejula and Jemperli showed promising treatment responses in certain patients with ER-positive, ...

In patients with triple-negative breast cancer, ctDNA was most commonly identified within six months after treatment, reflecting the disease’s typical pattern of early recurrence.

A reflective Christmas morning run, following a cancer diagnosis, inspires profound gratitude for life and a renewed commitment to living a meaningful life.

Targeting the estrogen receptor and HER2 pathways improved progression-free survival in patients with HR-positive, ...

CURE® spoke with an expert about follicular lymphoma, a disease that is still considered incurable. There have been a number ...

Embrace Gratitude: I must reflect on what I’m thankful for each year. This practice reshaped my perspective on life. Create a ...

Treatment with UGN-102 has shown promise as a non-surgical alternative when compared with a surgical approach for certain ...

A study showed that patients with prostate cancer should consider the long-term side effects of treatments before deciding on ...

Enhertu maintained HRQOL and neurological function in HER2-positive metastatic breast cancer patients, regardless of brain ...

The Food and Drug Administration has approved Ensacove for patients with ALK-positive locally advanced or metastatic ...